Carter's (CRI) PT Lowered to $100 at Monness, Crespi, Hardt
Tweet
Share
E-mailGet Alerts CRI Hot Sheet
Price: $32.00 --0%
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Rating Summary:
9 Buy, 11 Hold, 3 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 7 | New: 22
Join SI Premium – FREE
Monness, Crespi, Hardt analyst Jim Cartier lowered the price target on Carter's (NYSE: CRI) to $100.00 (from $115.00) while maintaining a Buy rating.
You May Also Be Interested In
- Morgan Stanley Downgrades Barclays Plc (BARC:LN) (BCS) to Equalweight
- MiniMed Group (MMED) PT Raised to $28 at BofA Securities
- Medtronic, Inc. (MDT) PT Raised to $104 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
